Session: 696 Spatial Signaling and Desensitization Mechanisms
(696.4) Spatial Compartmentation of mTORC1 Signaling at the Mitochondria
Monday, April 4, 2022
10:00 AM – 12:00 PM
Location: Exhibit/Poster Hall A-B - Pennsylvania Convention Center
Poster Board Number: B75
Ayse Sahan (University of California, San Diego, University of California, San Diego), Yanghao Zhong (University of California, San Diego, University of California, San Diego), Xin Zhou (University of California, San Diego), Danielle Schmitt (University of California, San Diego), Jin Zhang (University of California, San Diego, University of California, San Diego, University of California, San Diego)
Presenting Author University of California, San Diego, University of California, San Diego
The mechanistic target of rapamycin complex 1 (mTORC1) senses diverse signals to regulate cell growth and metabolism. The complex is present at the plasma membrane, nucleus, lysosomes, and the outer mitochondrial membrane. Such spatial compartmentation has been suggested to enhance signaling efficiency and specificity. For instance, we recently discovered nuclear mTORC1 activity, which is distinctly regulated from the canonical lysosomal mTORC1 (Zhou et al., 2020). Previous studies have shown that mTOR is present at the outer mitochondrial membrane (OMM), but it is not clear whether mTORC1 is active at this location and what the functional consequences are. To investigate this, we targeted our FRET-based mTORC1 activity reporter, TORCAR (Zhou et al., 2015), to the OMM and probed the subcellular activity of mTORC1. We found that platelet-derived growth factor (PDGF) stimulation increases mTORC1 activity at the OMM in addition to at the lysosome and in the nucleus, whereas insulin specifically stimulates mTORC1 activity at the OMM without affecting the lysosomal and nuclear activities. We further dissected the regulation of mitochondrial mTORC1 activity and applied a novel approach of identifying new mTORC1 substrates. Elucidating the signaling events that lead to subcellular mTORC1 activity at mitochondria and its downstream functions will increase our understanding of the roles that mTORC1 may play in diseases associated with altered metabolism or mitochondrial dysfunction, such as diabetes and cancer.
NIH/NICDR R01 DE030497 UCSD Graduate Training Program in Cellular and Molecular Pharmacology from NIGMS T32 GM007752